EQS-News: BIO-Europe 2026 to Convene Global Biopharma Leaders in Cologne as Dealmaking Confidence Grows

London, UK – October 27, 2026 – BIO-Europe 2026 will bring together more than 6,000 senior executives from the global biotech, pharmaceutical, and investment sectors in Cologne, Germany, November 9–11 ...
Börsennews

AUTO1 Group SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet. Den ...

EQS-News: Artprice by Artmarket presents a liber mundi, dixit Gemini: 'Dialogue Between a Thinker and AI' carries within it the serene, yet profound, echo of the greatest ...

Its subtitle, "The Great Revenge of Literary Minds and Humanists in a Digital Age," is not a call to confrontation, but the calm acknowledgment of a historical restauration of equilibrium. Leonardo da ...

EQS-News: Together for an AI-Powered Urban Future: Dahua Technology Showcases Practical AIoT Solutions …

Dahua Technology Showcases Practical AIoT Solutions at SCEWC 2026 05.11.2026, 14:00 Uhr von EQS News Jetzt kommentieren: 0 ...

PVA TePla AG: Correction of a release from 28/10/2026 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide ...

Correction of a release from 28/10/2026 according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution 02.11.2026 / 17:30 CET/CEST ...
Börsennews

Gerresheimer AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

k.A. k.A. k.A. k.A.
Börsennews

Fresenius Medical Care AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

Im Durchschnitt erleiden 7 von 10 Kleinanlegern Verluste beim Handel mit Turbo-Zertifikaten. Turbo-Zertifikate sind hoch risikoreiche Produkte und nicht für langfristige Anlagestrategien geeignet.